Your session is about to expire
← Back to Search
Mobile Health Intervention for Depression in Youth with HIV
Study Summary
This trial will create a digital therapy tool to help Ugandan teens with HIV and depression, using CBT to improve mental health and ART adherence.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am on antiretroviral therapy.I understand the study and am willing to complete it.I am between 14 and 17 years old.
- Group 1: Suubi-Mhealth
- Group 2: Waitlist Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this trial restricted to individuals under a certain age?
"In compliance with the enrolment criteria, those aged 14 to 17 can join this particular clinical trial."
What are the eligibility requirements for enrolling in this research?
"Eligibility requirements for this clinical trial include a diagnosed depression and an age range of 14 to 17 years old. At present, the study is seeking 278 participants."
Are there any additional participants required for this clinical investigation?
"Affirmative. The clinicaltrials.gov webpage reveals that this trial is immediately searching for able candidates, with the initial posting taking place on November 23rd of 2022 and last updated July 19th 2023. A total of 278 participants are needed to be recruited from 2 different medical facilities."
How many participants are being invited to join this medical trial?
"Affirmative. Clinicaltrials.gov states that this medical trial, initially published on November 23rd 2022, is still open to new participants. Specifically, 278 patients must be sourced from 2 different healthcare providers."
Share this study with friends
Copy Link
Messenger